Insiders · DWTX

DWTX insider transactions

Dogwood Therapeutics Inc. (DWTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for DWTX

• 50d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 50d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 50d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 50d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 141d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 141d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 141d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 141d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 151d
  Director Sealbond Ltd converted options into 24,453,588 shares (SEC Form 4)

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by Director Whitley Richard James

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by Director Thomas John C

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by Director Keefer David R

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 298d
  SEC Form 4 filed by Director De La Rosa Abel

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Whitley Richard James

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Keefer David R

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Thomas John C

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director De La Rosa Abel

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 401d
  SEC Form 3 filed by new insider Conjoint Inc.

  3 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 404d
  SEC Form 4 filed by Director Ck Life Sciences Intl (Holdings) Inc

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 555d
  SEC Form 3 filed by new insider Yu Ying Choi Alan Abel

  3 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 555d
  SEC Form 3 filed by new insider Toh Kean Meng Melvin

  3 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 555d
  New insider Sealbond Ltd claimed ownership of 211,383 shares (SEC Form 3)

  3 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)